[Form 4] Enact Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Enact Holdings, Inc. (ACT) reported insider awards for Rohit Gupta, President and CEO and director. On 09/08/2025 Mr. Gupta was issued three tranches of restricted stock units (RSUs) that will settle 1:1 into common shares: 171 RSUs, 201 RSUs and 245 RSUs. Each tranche reports a $0 price reflecting grant/reinvestment terms tied to a quarterly dividend of $0.21 per share paid on 09/08/2025.

The filing shows the reported beneficial ownership following these issuances as 31,593, 37,333 and 45,340 shares respectively for the three RSU lines. Vesting schedules are specified: the first tranche vests in three equal annual installments beginning 02/09/2024, the second beginning 02/16/2025 and the third beginning 02/21/2026. The Form 4 is signed by a power of attorney on 09/10/2025.

Positive

• RSU grants were issued to the CEO/director, reinforcing alignment of management incentives with shareholders
• Dividend reinvestment generated additional RSUs at a $0.21 dividend per share paid on 09/08/2025
• Clear vesting schedules disclosed for each RSU tranche, showing staged alignment over time

Negative

• None.

Insights

Securities/Equity Compensation Analyst

TL;DR: CEO/director received modest RSU grants and dividend-reinvestment RSUs, following standard vesting schedules.

The filing documents three separate RSU issuances to Rohit Gupta on 09/08/2025 totaling 617 RSUs vested across distinct schedules. Each RSU converts 1:1 into common stock and some additional RSUs resulted from a $0.21 quarterly dividend reinvestment. The report lists post-transaction beneficial ownership figures for each RSU line: 31,593, 37,333, and 45,340 shares respectively. This pattern is consistent with routine equity compensation and dividend reinvestment mechanics rather than an open-market purchase or sale.

Corporate Governance Expert

TL;DR: Transactions reflect executive compensation administration, not a change in control or material outside action.

The Form 4 indicates the reporting person holds roles as both President and CEO and a director, and the reported activity consists of RSU issuances that vest over multi-year schedules. The inclusion of a power-of-attorney signature and explicit vesting commencement dates shows standard governance treatment of equity awards. There is no disclosure in this filing of option exercises, open-market trades, board changes, or other governance events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gupta Rohit

(Last) (First) (Middle)

C/O ENACT HOLDINGS, INC.

8325 SIX FORKS ROAD

(Street)

RALEIGH NC 27615

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enact Holdings, Inc. [ ACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	09/08/2025		A		171		(2)	(2)	Common Stock	171	$0(3)	31,593	D
Restricted Stock Units	(1)	09/08/2025		A		201		(4)	(4)	Common Stock	201	$0(3)	37,333	D
Restricted Stock Units	(1)	09/08/2025		A		245		(5)	(5)	Common Stock	245	$0(3)	45,340	D

Explanation of Responses:

1. Each restricted stock unit will settle into shares of Issuer common stock on a 1:1 basis.

2. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 9, 2024

3. Additional restricted stock units acquired pursuant to reinvestment terms in the restricted stock unit award agreement resulting from a quarterly dividend at $0.21 per share, paid on September 8, 2025.

4. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 16, 2025

5. Restricted Stock Units vest and convert to Common Stock in three equal annual installments beginning on February 21, 2026

Remarks:

	/s/ Joe Jacumin, by power of attorney	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Enact Holdings (ACT) report on 09/08/2025?

Rohit Gupta received three RSU issuances on 09/08/2025 of 171, 201, and 245 restricted stock units that settle 1:1 into common stock.

What were the beneficial ownership totals reported after the transactions?

The Form 4 shows post-transaction beneficial ownership figures of 31,593, 37,333, and 45,340 shares for the respective RSU lines.

Did the RSUs have a purchase price or cost reported?

The RSUs are reported with a price of $0 reflecting issuance/reinvestment terms; additional RSUs resulted from a $0.21 quarterly dividend paid on 09/08/2025.

What are the vesting commencement dates for the RSU tranches?

Vesting begins in three equal annual installments starting on 02/09/2024, 02/16/2025, and 02/21/2026 for the three respective RSU tranches.

Who signed the Form 4 and when was it filed?

The Form 4 bears a signature by /s/ Joe Jacumin, by power of attorney dated 09/10/2025.